No OS Benefit From HIPEC in Colorectal Cancer

Bryant FurlowJun 4, 2018Overall, patients with mCRC and isolated peritoneal carcinomatosis did not benefit when hyperthermic intraperitoneal chemotherapy was added to surgery.

Source: CancerNetwork - June 4, 2018 Category: Cancer & Oncology Authors: A Source Type: news